HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.

Abstract
Much of the efficiency of the immune system is attributed to the high degree of spatial and temporal organization in the secondary lymphoid organs. Signalling through the lymphotoxin (LT) pathway is a crucial element in the maintenance of this organized microenvironment. The effect of altering lymphoid microenvironments on immune responses remains relatively unexplored. Inhibitors of the LT and LIGHT pathways have been shown to reduce disease in a wide range of autoimmune models. This approach has provided a tool to probe the effect of manipulation of the microenvironment on both normal and pathological immune responses.
AuthorsJennifer L Gommerman, Jeffrey L Browning
JournalNature reviews. Immunology (Nat Rev Immunol) Vol. 3 Issue 8 Pg. 642-55 (Aug 2003) ISSN: 1474-1733 [Print] England
PMID12974479 (Publication Type: Journal Article, Review)
Chemical References
  • Lymphotoxin-alpha
  • Receptors, Tumor Necrosis Factor
Topics
  • Animals
  • Autoimmune Diseases (immunology)
  • Dendritic Cells, Follicular (immunology)
  • Humans
  • Lymphoid Tissue (immunology)
  • Lymphotoxin-alpha (antagonists & inhibitors, immunology)
  • Receptors, Tumor Necrosis Factor (immunology)
  • Signal Transduction (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: